Clinical Trial Update: Hybrid Effectiveness-Implementation Trial to Integrate Precision Skin Cancer Risk Feedback in FQHCs [NA]

View source ↗

Summary

An ongoing trial is evaluating integrating precision skin cancer risk feedback into Federally Qualified Health Centers to improve uptake and implementation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skin Cancer

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Skin Cancer | NA | Status: RECRUITING